Skip Nav Destination
Abstract CN01-03: T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Mol Cancer Ther (2019) 18 (12_Supplement): CN01-03.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Franziska Lang
- Barbara Schrörs
- Martin Löwer
- Özlem Türeci
- Ugur Sahin
Nature Reviews Drug Discovery (2022) 21 (4): 261.
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
- Kedar Kirtane
- Hany Elmariah
- Christine H Chung
- Daniel Abate-Daga
Journal for ImmunoTherapy of Cancer (2021) 9 (7): e002723.
- Miganoosh Simonian
- Mozhan Haji Ghaffari
- Babak Negahdari
Iranian Biomedical Journal (2021) 25 (3): 140.
RSS Feeds